Cordis Corp-Product Pipeline Analysis, 2017 Update

Cordis Corp-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME815PD
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company's cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic catheters, steerable guidewires and PTCA Balloons. It also offers products such as access accessories, vena cava filters, crossing devices, guiding catheters, PTA balloons, self expanding stents, specialty balloons, hydrophilic nitinol guidewire, balloon expandable stents, transhepatic biliary stent, carotid stent system and vascular closure devices among others. The company has operations in Japan, Canada, Europe, Middle East and Africa. Cordis is headquartered in Fremont, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Cordis Corp

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Cordis Corp Company Overview 6

Cordis Corp Company Snapshot 6

Cordis Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Cordis Corp-Pipeline Analysis Overview 9

Cordis Corp-Key Facts 9

Cordis Corp-Major Products and Services 10

Cordis Corp Pipeline Products by Development Stage 11

Cordis Corp Ongoing Clinical Trials by Trial Status 13

Cordis Corp Pipeline Products Overview 15

Corio Pimecrolimus-eluting Stent 15

Corio Pimecrolimus-eluting Stent Product Overview 15

CYPHER ELITE 16

CYPHER ELITE Product Overview 16

ELITECROSS Support Catheter 17

ELITECROSS Support Catheter Product Overview 17

EP Contact Force Sensing Catheter Enabled By CARTO 3 18

EP Contact Force Sensing Catheter Enabled By CARTO 3 Product Overview 18

EP Lesion Assessment Device 19

EP Lesion Assessment Device Product Overview 19

FlexStent Femoropopliteal Self Expanding Stent System-SFA 20

FlexStent Femoropopliteal Self Expanding Stent System-SFA Product Overview 20

FlexStent Femoropopliteal Self Expanding Stent System-SFA Clinical Trial 21

FlexStent Self Expanding Below-The-Knee Venous Stent System 22

FlexStent Self Expanding Below-The-Knee Venous Stent System Product Overview 22

FlexStent Self Expanding Venous Stent System 23

FlexStent Self Expanding Venous Stent System Product Overview 23

Flow Diverter 24

Flow Diverter Product Overview 24

INCRAFT AAA Stent Graft 25

INCRAFT AAA Stent Graft Product Overview 25

INCRAFT AAA Stent Graft Clinical Trial 26

NEVO Sirolimus-Eluting Coronary Stent 27

NEVO Sirolimus-Eluting Coronary Stent Product Overview 27

Next Generation Coronary Stent 28

Next Generation Coronary Stent Product Overview 28

Next Generation EMPIRA PTCA Balloon 29

Next Generation EMPIRA PTCA Balloon Product Overview 29

NOGA Guided Myostar Injection Catheter 30

NOGA Guided Myostar Injection Catheter Product Overview 30

NOGA Guided Myostar Injection Catheter Clinical Trial 31

SymBio Pimecrolimus/Paclitaxel-eluting Stent 32

SymBio Pimecrolimus/Paclitaxel-eluting Stent Product Overview 32

Tibial SE FlexStent 33

Tibial SE FlexStent Product Overview 33

Cordis Corp-Key Competitors 34

Cordis Corp-Key Employees 35

Cordis Corp-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Cordis Corp, Recent Developments 37

May 12, 2016: Biosensors Announces Strategic Agreement With Cardinal Health 37

Mar 04, 2016: Palmaz Scientific Announces Chapter 11 Filing; Seeks Prospective Buyers for Its Breakthrough Technology 37

Nov 19, 2015: Strong Results Reported for the Cordis INCRAFT AAA Stent Graft System with New Four-Year Data from the INNOVATION Trial 38

Oct 09, 2015: Cardinal Health and Cordis Debut Combined Offering of Cardiovascular Product Advances at TCT 2015 39

Jun 08, 2015: Cordis Expands Crossing Portfolio by the launch of OUTBACK Elite Re-Entry Catheter for the Treatment of Chronic Total Occlusions 39

Jun 08, 2015: Cordis Expands Crossing Portfolio by the Launch of ELITECROSS Support Catheter for the Treatment of Chronic Total Occlusions 40

Jan 05, 2015: Acacia Subsidiary Enters into Settlement and Patent License Agreement with Cordis 41

Nov 19, 2014: Cordis Leads With Strong Podium Presence At VEITH 2014 With Presentation Of S.M.A.R.T. Stent Data 41

Nov 19, 2014: Cordis Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT System Data 41

Sep 10, 2014: Cordis Launches INCRAFT AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms 42

Appendix 43

Methodology 43

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Cordis Corp Pipeline Products by Equipment Type 7

Cordis Corp Pipeline Products by Development Stage 11

Cordis Corp Ongoing Clinical Trials by Trial Status 13

List of Tables

Cordis Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Cordis Corp Pipeline Products by Equipment Type 7

Cordis Corp Pipeline Products by Indication 8

Cordis Corp Ongoing Clinical Trials by Trial Status 8

Cordis Corp, Key Facts 9

Cordis Corp, Major Products and Services 10

Cordis Corp Number of Pipeline Products by Development Stage 11

Cordis Corp Pipeline Products Summary by Development Stage 12

Cordis Corp Ongoing Clinical Trials by Trial Status 13

Cordis Corp Ongoing Clinical Trials Summary 14

Corio Pimecrolimus-eluting Stent-Product Status 15

Corio Pimecrolimus-eluting Stent-Product Description 15

CYPHER ELITE-Product Status 16

CYPHER ELITE-Product Description 16

ELITECROSS Support Catheter-Product Status 17

ELITECROSS Support Catheter-Product Description 17

EP Contact Force Sensing Catheter Enabled By CARTO 3-Product Status 18

EP Contact Force Sensing Catheter Enabled By CARTO 3-Product Description 18

EP Lesion Assessment Device-Product Status 19

EP Lesion Assessment Device-Product Description 19

FlexStent Femoropopliteal Self Expanding Stent System-SFA-Product Status 20

FlexStent Femoropopliteal Self Expanding Stent System-SFA-Product Description 20

FlexStent Femoropopliteal Self Expanding Stent System-SFA-Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-expanding Stent System Study 21

FlexStent Self Expanding Below-The-Knee Venous Stent System-Product Status 22

FlexStent Self Expanding Below-The-Knee Venous Stent System-Product Description 22

FlexStent Self Expanding Venous Stent System-Product Status 23

FlexStent Self Expanding Venous Stent System-Product Description 23

Flow Diverter-Product Status 24

Flow Diverter-Product Description 24

INCRAFT AAA Stent Graft-Product Status 25

INCRAFT AAA Stent Graft-Product Description 25

INCRAFT AAA Stent Graft-A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms (INSPIRATION) 26

INCRAFT AAA Stent Graft-A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms 26

INCRAFT AAA Stent Graft-Compassionate Use of the Incraft AAA Stent Graft System 26

NEVO Sirolimus-Eluting Coronary Stent-Product Status 27

NEVO Sirolimus-Eluting Coronary Stent-Product Description 27

Next Generation Coronary Stent-Product Status 28

Next Generation Coronary Stent-Product Description 28

Next Generation EMPIRA PTCA Balloon-Product Status 29

Next Generation EMPIRA PTCA Balloon-Product Description 29

NOGA Guided Myostar Injection Catheter-Product Status 30

NOGA Guided Myostar Injection Catheter-Product Description 30

NOGA Guided Myostar Injection Catheter-A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction 31

SymBio Pimecrolimus/Paclitaxel-eluting Stent-Product Status 32

SymBio Pimecrolimus/Paclitaxel-eluting Stent-Product Description 32

Tibial SE FlexStent-Product Status 33

Tibial SE FlexStent-Product Description 33

Cordis Corp, Key Employees 35

Cordis Corp, Other Locations 36

Glossary 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Bolton Medical Inc, Argon Medical Devices Inc., Abbott Vascular Inc.

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com